Real-time enrollment status for this advanced solid tumors clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 8:00 PM UTC
| NCT Number | NCT05719558 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 798 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Astellas Pharma Global Development, Inc. |
| Last Updated on CT.gov | July 23, 2026 (Jul 23, 2026) |
As of August 27, 2026: Clinical trial NCT05719558 is currently recruiting participants. This phase1 study for advanced solid tumors is actively seeking new participants at 15 locations across the United States. The study is sponsored by Astellas Pharma Global Development, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05719558 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05719558 was last updated Jul 23, 2026 (July 23, 2026). HelloStudys verifies this status automatically.